|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS12023 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 |
| CAS編號(hào) | |
| 抗體名 | Anti-UVRAG/DHTX |
| 克隆性 | |
| 靶點(diǎn) | 詳見說(shuō)明書 |
| 適應(yīng)物種 | 詳見說(shuō)明書 |
| 形態(tài) | 詳見說(shuō)明書 |
| 宿主 | 詳見說(shuō)明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說(shuō)明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from Human UVRAG/DHTX |
產(chǎn)品訂購(gòu)信息：
英文名稱 Anti-UVRAG/DHTX
中文名稱 抑制基因UVRAG抗體品牌
別 名 DHTX; Disrupted in heterotaxy; p63; UV radiation resistance associated; UV radiation resistance associated gene; UV radiation resistance associated gene protein; UV radiation resistance-associated gene protein; UVRAG; UVRAG_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Horse
產(chǎn)品類型 一抗
研究領(lǐng)域 心 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 78kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from Human UVRAG/DHTX
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
抑制基因UVRAG抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 UVRAG, also known as p63 or DHTX, is a 699 amino acid cytoplasmic protein. UVRAG has been shown to activate the BECN1/PI 3-kinase complex, which promotes autophagy. Autophagy is the degradation of cellular proteins in the lysosomes, and when this pathway is suppressed, cell growth is deregulated. Mutations in the gene encoding UVRAG have been associated with colon cancer, suggesting that UVRAG is also involved in suppressing the proliferation and tumorigenicity of human colon cancer cells. UVRAG has been found to complement the ultraviolet sensitivity of xeroderma pigmentosum group C cells. Ubiquitously expressed, UVRAG is found at highest levels in kidney, lung, liver and brain. UVRAG contains one C2 domain, which is thought to be involved in calcium-dependent phospholipid binding.
Subunit : Forms a complex with BECN1, PIK3C3 and PIK3R4. A subpopulation of these complexes also harbor KIAA0226/Rubicon. UVRAG-containing complexes never including ATG14, both forming mutually exclusive complexes with BECN1 through direct competition. Directly interacts with FEZ1 and SCOC. The interaction with SCOC is reduced by amino acid starvation, but the complex is stabilized in the presence of FEZ1.
Subcellular Location : Late endosome. Lysosome. Early endosome. Colocalizes with RAB9-positive compartments involved in retrograde transport from late endosomes to trans-Golgi network. Colocalization with early endosomes is only partial.
Tissue Specificity : Highly expressed in brain, lung, kidney and liver.
DISEASE : Note=A chromosomal aberration involving UVRAG has been observed in a patient with heterotaxy (left-right axis malformation). Inversion Inv(11)(q13.5;q25).
Similarity : Contains 1 C2 domain.
Database links : UniProtKB/Swiss-Prot: Q9P2Y5.1
UVRAG抑制基因可對(duì)自體吞噬起到調(diào)控機(jī)制，以完成自我運(yùn)輸調(diào)節(jié)機(jī)制。此外，UVRAG抑制因子還是包膜上物質(zhì)轉(zhuǎn)運(yùn)通路上的重要效應(yīng)蛋白，它可調(diào)控細(xì)胞的內(nèi)吞和自體吞噬作用。
BrdU(Human Bromodeoxyuridine) ELISA Kit 人溴脫氧核苷尿嘧啶Multi-class antibodies規(guī)格： 48T
Anti-PIWIL1 piwi樣1蛋白抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh HIPK3 Fas相互作用蛋白激酶3抗體 規(guī)格 0.2ml
OVA sIgG(Human ovalbumin specific IgG) ELISA Kit 人卵清蛋白特異性IgG 96T
STK18 英文名稱： 絲酸/蘇酸蛋白激酶18 0.2ml
Connexin-37 英文名稱： 間隙連接蛋白37抗體 0.1ml
Anti-PIWIL1 piwi樣1蛋白抗體Multi-class antibodies規(guī)格： 0.1ml
Anti-Phospho-FHIT (Tyr114) /FITC 熒光素標(biāo)記抗磷酸化脆性組氨酸三聯(lián)體抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-Phospho-NFKBp65 (Ser276)/FITC 熒光素標(biāo)記磷酸化細(xì)胞核因子NF-κB p65抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh BubR1 有絲分裂檢驗(yàn)點(diǎn)蛋白BubR1抗體 規(guī)格 0.2ml
AVPR2(arginine vasopressin receptor 2) 精酸加壓素受體2抗原 0.5mg
HOOK1 英文名稱： HOOK1蛋白抗體 0.2ml
Rhesus antibody Rh RNF126 環(huán)指蛋白126抗體 規(guī)格 0.2ml
Anti-Phospho-NFKBp65 (Ser276)/FITC 熒光素標(biāo)記磷酸化細(xì)胞核因子NF-κB p65抗體IgGMulti-class antibodies規(guī)格： 0.2ml
PLAP(Human Placental alkaline pkosphatase) ELISA Kit 人胎盤堿性磷酸酶Multi-class antibodies規(guī)格： 48T
Anti-Phospho-NPM (Thr95) 磷酸化核仁磷酸蛋白抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh IGSF21 免疫球蛋白超家族成員21抗體 規(guī)格 0.2ml
AsAb ELISA Kit 大鼠抗抗體 96T
Phospho-PTEN(Ser385) 英文名稱： 磷酸化抑制基因PTEN抗體 0.1ml
CKIP-1 英文名稱： 酪蛋白激酶2相互作用蛋白1抗體 0.2ml
Anti-Phospho-NPM (Thr95) 磷酸化核仁磷酸蛋白抗體Multi-class antibodies規(guī)格： 0.1ml
CDH13 Others Rat 大鼠 CDH13 / Cadherin-13 / H Cadherin 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
大鼠腎上腺嗜鉻細(xì)胞瘤細(xì)胞;PC-12 [PC12]
CM-M123小鼠角膜成纖維細(xì)胞完全培養(yǎng)基100mL
TU212細(xì)胞，人細(xì)胞 人臍內(nèi)皮(具有T24細(xì)胞特性),ECV-304細(xì)胞 倉(cāng)鼠卵巢細(xì)胞;Lec1
C4-2(人細(xì)胞) 5×106cells/瓶×2
MET Others Human 人 c-MET / HGFR 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0456TM4(正常小鼠Sertoli細(xì)胞)5×106cells/瓶×2
SIGIRR Others Human 人 SIGIRR / TIR8 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人膀胱基質(zhì)成纖維細(xì)胞RNAHBdSF miRNA5 μg
T24細(xì)胞，人膀胱移行細(xì)胞癌細(xì)胞 大鼠細(xì)胞(wistar 大鼠),CBRH7919細(xì)胞 RN-c, 大鼠皮質(zhì)神經(jīng)元
Ishikawa(人細(xì)胞) 5×106cells/瓶×2
hPC-PL-c 人類胎盤周細(xì)胞(hPC-PL) 500,000cells 小鼠巨噬細(xì)胞MMa
抑制基因UVRAG抗體品牌 CL-0454TE-11(人細(xì)胞)5×106cells/瓶×2
HA Others H7N9 甲型 H7N9 (A/Shanghai/2/2013) 血凝素 (Hemagglutinin / HA) 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人膀胱平滑肌細(xì)胞RNAHBdSMC miRNA5 μg
兔眼Tenon's囊成纖維細(xì)胞;RYTF 細(xì)胞，Hep 3B2.1-7細(xì)胞 IR983F細(xì)胞，大鼠細(xì)胞
人男性正常細(xì)胞;Hs68
HA Others H5N1 甲型 H5N1 (A/Hong Kong/483/97) 血凝素 (Hemagglutinin / HA) 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 抑制基因UVRAG抗體品牌 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；
3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定：
1）抑制基因UVRAG抗體品牌 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol。抗體親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
|
|
|
|
|
